Human Influenza A/PR/8/34 (H1N1) Purified Virus, UV-Inactivated
Catalog #: 10-273-500
Size: 0.5 mg
Human Influenza A/PR/8/34 (H1N1) purified virus inactivated by ultraviolet light irradiation.
For research use only.
APPLICATION FOR USE
- Hemagglutination Assay (HA)
- ELISpot Assay
- Hemagglutination Inhibition Assay (HAI)
- Virus Ultrastructural Studies
- Antibody Screening/Titration
- Antibody Production
- Lymphocyte Stimulation Assay
QUALITY CONTROL TESTING INCLUDES
- Sterility
- Validation of Inactivation
- Hemagglutination Assay
- Protein Concentration
- VPC by TEM
SHIPPING AND STORAGE:
This product is shipped frozen on dry ice. Store at -70°C upon receipt. Avoid multiple freeze-thaw cycles as product degradation may result.
RECOMMENDATIONS:
Upon thawing, centrifuge the vial for a few seconds to remove residual droplets from the lid.
SAFE HANDLING RECOMMENDATIONS:
This inactivated biological preparation should be handled in accordance with biosafety guidelines defined in the BMBL, NIH-CDC HHS Publication No. (CDC) 21-1112.
REFERENCE ARTICLES
Dudhgaonkar, S., Ranade, S., Nagar, J., Subramani, S., Prasad, D., Karunanithi, P., Srivastava, R., Venkatesh, K., Selvam, S., and Krishnamurthy, P. et al. (2017). Selective IRAK4 Inhibition Attenuates Disease in Murine Lupus Models and Demonstrates Steroid Sparing Activity. The Journal Of Immunology 198, 1308-1319. https://doi.org/10.4049/jimmunol.1600583
Koopman, G., Mooij, P., Dekking, L., Mortier, D., Nieuwenhuis, I., van Heteren, M., Kuipers, H., Remarque, E., Radoševi?, K., and Bogers, W. (2016). Correlation between Virus Replication and Antibody Responses in Macaques following Infection with Pandemic Influenza A Virus. Journal Of Virology 90, 1023-1033. https://doi.org/10.1128/jvi.02757-15
Pugh, N., Edwall, D., Lindmark, L., Kousoulas, K., Iyer, A., Haron, M., and Pasco, D. (2015). Oral administration of a Spirulina extract enriched for Braun-type lipoproteins protects mice against influenza A (H1N1) virus infection. Phytomedicine 22, 271-276. https://doi.org/10.1016/j.phymed.2014.12.006
- New Product
- Available as Custom Product-Discontinued
- Limited Quantities Remaining-Discontinued
- Call For Availability
- Biohazard Category A
- Biohazard Category B
-
10-270-100Rubella (HPV77 Strain) Purified Virus, UV-Inactivated100 µg
-
20-275-200HCMV (AD169 Strain) Purified Virus, ß-PL Inactivated, VPC200 µL
-
20-247-200RSV-A (A2 Strain) Purified Virus, UV-Inactivated, VPC200 µL
-
10-150-100SIV (mac251 Strain) Purified Viral Lysate100 µg
-
10-283-500VZV (Rod Strain) Purified Virus, UV-Inactivated0.5 mg
-
10-282-500VZV (Rod Strain) Purified Viral Lysate0.5 mg
-
10-255-000Vaccinia (WR Strain) Purified Virus, UV-Inactivated1.0 mg
-
10-279-001Toxoplasma gondii (RH Strain) Purified Tachyzoites Lysate1.0 mL
-
10-279-025Toxoplasma gondii (RH Strain) Purified Tachyzoites Lysate25 mL
-
10-153-000SRV-1 (Macaque Strain) Purified Viral Lysate1.0 mg
-
10-248-000RSV-A (A2 Strain) Purified Viral Lysate1.0 mg
-
10-263-000Neisseria gonorrhoeae (NCTC 8375 [B 5025] Strain) Heat-Inactivated Cells1.0 mL
-
10-267-500Human Influenza A/PR/8/34 (H1N1) Purified Virus, ß-PL Inactivated0.5 mg
-
10-276-000Human Influenza A/2/Japan/305/57 (H2N2) Purified Virus, UV-Inactivated1.0 mg
-
10-285-500Human Influenza A/California/4/2009 (H1N1) Purified Virus (Swine-Origin), UV-Inactivated0.5 mg
-
10-113-000HTLV-I (MT-2 Strain) Purified Viral Lysate1.0 mg
-
10-146-000HSV-2 (G Strain) Purified Viral Lysate1.0 mg
-
10-145-000HSV-1 (MacIntyre Strain) Purified Viral Lysate1.0 mg
-
10-128-000HIV-2 (NIH-Z Strain) Purified Viral Lysate1.0 mg
-
10-119-000HIV-1 (IIIB Strain) Purified Viral Lysate1.0 mg
-
10-121-000HIV-1 (IIIB Strain) Purified Viral Lysate1.0 mg
-
10-241-500HHV-6A (GS Strain) Purified Viral Lysate0.5 mg
-
10-147-000EBV (B95-8 Strain) Purified Viral Lysate1.0 mg
-
10-272-000Dengue-1 (Hawaii Strain) Purified Viral Lysate1.0 mL
-
10-265-000Chlamydia trachomatis LGV-II (434 Strain) Heat-Inactivated Elementary Bodies1.0 mL
